Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kintara Therapeutics Inc (KTRA)

Kintara Therapeutics Inc (KTRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kintara Therapeutics Inc 9920 PACIFIC HEIGHTS BLVD SUITE 150 SAN DIEGO CA 92121 USA

www.kintara.com P: 858-350-4364

Description:

Kintara Therapeutics Inc. is a biopharmaceutical company. It is focused on the development of new solid tumor cancer therapies. The company's program includes VAL-083 for GBM and REM-001 for cutaneous metastatic breast cancer, which are in clinical stage. Kintara Therapeutics Inc. is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 6,168
Enterprise Value, $K 15,278
Shares Outstanding, K 39,038
Annual Sales, $ 0 K
Annual Net Income, $ -14,650 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,020 K
EBIT, $ -10,630 K
EBITDA, $ -7,340 K
60-Month Beta 0.57
% of Insider Shareholders 4.30%
% of Institutional Shareholders 0.62%
Float, K 37,359
% Float 95.70%
Short Volume Ratio 0.39

Growth:

1-Year Return -94.69%
3-Year Return -99.77%
5-Year Return -99.91%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 96.57%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.24 on 02/14/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -5.96
EPS Growth vs. Prev Qtr 86.89%
EPS Growth vs. Prev Year 88.57%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 11/14/22

KTRA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -305.69%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.02
Interest Coverage -1.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar